Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enforcement Activities

This article was originally published in SRA

Executive Summary

Prescription warning for cosmetic lens suppliers in US

Prescription warning for cosmetic lens suppliers in US

The US Federal Trade Commission (FTC) is warning sellers of cosmetic contact lenses not to sell their products to consumers without a valid prescription1.

The FTC sent warning letters on 12 October to 15 sellers of non-corrective lenses who appeared to be providing their products without a prescription, with guidance on their obligations under the Contact Lens Rule. According to the rule, sellers of both corrective and non-corrective cosmetic contact lenses must have a copy of a valid contact lens prescription before dispensing their products to consumers. Failure to obtain a copy of a prescription or verify it with prescribers can result in civil penalties of up to $11,000.

Congress enacted the Fairness to Contact Lens Consumers Act in 2003, which imposed new prescription release and verification requirements on contact lens prescribers and sellers. The FTC issued the Contact Lens Rule in 2004 to implement the act, and Congress amended the act in 2005 to require prescriptions for purely cosmetic lenses.

References

1. FTC press release, 17 October 2007, www.ftc.gov/opa/2007/10/contacts.shtm

Latest Headlines
See All
UsernamePublicRestriction

Register

PS113497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel